Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patients with non-alcoholic fatty liver disease and metabolic syndrome
出版年份 2021 全文链接
标题
Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patients with non-alcoholic fatty liver disease and metabolic syndrome
作者
关键词
Non-alcoholic fatty liver disease, Metabolic syndrome, Lipid indices, Liver fibrosis scores
出版物
Arab Journal of Gastroenterology
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-03-02
DOI
10.1016/j.ajg.2020.12.005
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease
- (2018) Xia Sheng et al. HORMONE AND METABOLIC RESEARCH
- Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue
- (2018) Sofia Dias et al. International Journal of Endocrinology
- Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance
- (2017) Jinghua Song et al. GYNECOLOGICAL ENDOCRINOLOGY
- Metabolic and Inflammatory Changes with Orlistat and Sibutramine Treatment in Obese Malaysian Subjects
- (2017) Belqes Abdullah Mohammad Al-Tahami et al. JOURNAL OF NIPPON MEDICAL SCHOOL
- Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients
- (2017) Rashid Ali Khan et al. Therapeutics and Clinical Risk Management
- A nem alkoholos zsírmáj mint a metabolikus szindróma komponense és kauzális kapcsolatai egyéb kórképekkel
- (2017) Tamás Halmos et al. ORVOSI HETILAP
- Conicity Index and Waist-to-Hip Ratio Are Superior Obesity Indices in Predicting 10-Year Cardiovascular Risk Among Men and Women
- (2015) Nima Motamed et al. CLINICAL CARDIOLOGY
- The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease
- (2015) Daniele Pastori et al. DIGESTIVE AND LIVER DISEASE
- Nonalcoholic fatty liver disease and statins
- (2015) Konstantinos Tziomalos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Effect of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
- (2015) N. M. Aldekhail et al. Obesity Reviews
- Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2015) Yoshihisa Takahashi WORLD JOURNAL OF GASTROENTEROLOGY
- Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index
- (2015) Qing Pang WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance
- (2014) Tingting Du et al. Cardiovascular Diabetology
- New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease
- (2014) Amirhossein Sahebkar et al. EXPERT OPINION ON PHARMACOTHERAPY
- Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults
- (2012) Ryuichi Kawamoto et al. Cardiovascular Diabetology
- The role of lipid droplets in metabolic disease in rodents and humans
- (2011) Andrew S. Greenberg et al. JOURNAL OF CLINICAL INVESTIGATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started